CBS 2019
CBSMD教育中心
English

经皮左心耳封堵

科研文章

荐读文献

Left Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17 Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants: A Nationwide Propensity Score–Weighted Study Stretch-induced sarcoplasmic reticulum calcium leak is causatively associated with atrial fibrillation in pressure-overloaded hearts Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Results From the CABANA Trial Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry
|<< 1 2 3 4 >>|

ConsensusVolume 76, Issue 5, August 2020

JOURNAL:J Am Coll Cardiol. Article Link

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

GF Tomaselli, KW Mahaffey, A Cuker et al. Keywords: ACC Expert Consensus Decision Pathway; apixaban; atrial fibrillation; betrixaban; dabigatran; edoxaban; rivaroxaban; venous thromboembolism; warfarin

Full Text PDF